{"id":54962,"name":"GE HEALTHCARE TECHNOLOGIES INC.","slug":"ge-healthcare-technologies-inc","state":"IL","country":"United States of America","description":"Global medical technology, pharmaceutical diagnostics and digital solutions company.","totalSpending":2950000,"filings":13,"yearlySpending":[{"year":2023,"income":620000},{"year":2024,"income":680000},{"year":2025,"income":1650000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"CPI","display":"Computer Industry"},{"code":"CPT","display":"Copyright/Patent/Trademark"},{"code":"CSP","display":"Consumer Issues/Safety/Products"},{"code":"HCR","display":"Health Issues"},{"code":"MAN","display":"Manufacturing"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"SCI","display":"Science/Technology"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"TEC","display":"Telecommunications"},{"code":"TRD","display":"Trade (domestic/foreign)"},{"code":"VET","display":"Veterans"}],"firms":["GE HEALTHCARE TECHNOLOGIES INC."],"lobbyists":["ADAM FROMM","BETSY TOWER","MARCELLA ORRIN"],"govEntities":["Commerce, Dept of (DOC)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","U.S. Trade Representative (USTR)","Treasury, Dept of","White House Office","Office of Management & Budget (OMB)"],"sampleDescriptions":["Issues impacting: artificial intelligence and cybersecurity; corporate taxation; funding for health care including government research; health care and public health; manufacturing; medical device and","Issues impacting: artificial intelligence and cybersecurity; corporate taxation; funding for health care including government research; health care and public health; manufacturing; medical device and","Issues impacting: artificial intelligence and cybersecurity; corporate taxation; funding for health care including government research; health care and public health; manufacturing; medical device and","Issues impacting: artificial intelligence and cybersecurity; corporate taxation; funding for health care including government research; health care and public health; manufacturing; medical device and","Issues impacting: artificial intelligence and cybersecurity; corporate taxation; funding for health care including government research; health care and public health; manufacturing; medical device and"]}